Company Recalls Nearly All Sterile Products Manufactured this Year

More than 600 lots of products recalled by Wells Pharmacy Network.

The FDA recently announced a recall of all sterile human and veterinary products from the Wells Pharmacy Network, manufactured between February 22, 2016 and September 14, 2016.

The recall was issued due to the FDA’s concern over a lack of sterility assurance, according to a press release. The recall affects as many as 595 different lots of products, effecting humans and as many as 31 lots of veterinary products.

If administered, a product intended to be sterile that has been contaminated could result in a serious or life-threatening infection. Thus far, no vial or any lot has been found to be non-sterile and no adverse events have been reported.

However, the FDA recommends discontinuation of the products immediately if it is on the recall list. Any unused products should be quarantined until proper return instructions have been provided.

Healthcare providers who have dispensed these sterile products between the stated dates for a patient to use outside of the provider’s office should inform the patient immediately, the FDA reports. Adverse events experienced by humans can be reported through the FDA’s MedWatch Adverse Event Reporting program, and adverse events experienced by animals can also be reported to the FDA.

While no adverse events have been experienced, Wells Pharmacy Network has issued the recall to ensure the safety of their consumers.